Zio ECG Utilization Software (ZEUS) System vs VX1+

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by iRhythm Technologies
VS
by Volta Medical

AI Verdict

While both are AI-powered tools within cardiology, their applications are distinct. The Zio ECG Utilization Software (ZEUS) System focuses on long-term, remote ECG monitoring for arrhythmia diagnosis and management, leveraging wearable data. In contrast, VX1+ provides real-time assistance to electrophysiologists during cardiac ablation procedures by identifying abnormal electrograms. Therefore, they serve different phases of cardiac care, making them adjacent rather than direct competitors.

Choose Zio ECG Utilization Software (ZEUS) System if…

Choose the Zio ECG Utilization Software (ZEUS) System if you require a comprehensive, AI-powered solution for long-term, non-invasive outpatient cardiac arrhythmia monitoring and diagnosis. This system is ideal for identifying intermittent or elusive arrhythmias over an extended period (up to 14 days) using wearable biosensors, providing detailed end-of-wear reports for physician review and ongoing patient management.

View Zio ECG Utilization Software (ZEUS) System →

Choose VX1+ if…

Choose VX1+ if your electrophysiology lab needs real-time, AI-driven assistance during cardiac ablation procedures for atrial fibrillation and atrial tachycardia. This software is specifically designed to help electrophysiologists identify abnormal electrograms and optimize ablation targets directly within the operating room, integrating seamlessly with existing EP recording and 3D mapping systems.

View VX1+ →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Zio ECG Utilization Software (ZEUS) System VX1+
Deployment Cloud-based. Software, compatible with most multipolar catheters and mapping technologies used in operating rooms or electrophysiology labs.
BAA Available Yes AI-estimated Unknown
FDA Status Yes AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Zio ECG Utilization Software (ZEUS) System

Tool A provides a more versatile and accessible user experience with its ZioSuite web portal and mobile application, allowing healthcare professionals to review comprehensive reports remotely. While Tool B offers a simple interface for real-time procedural use, Tool A's broader platform caters to a wider range of user interactions and post-procedure analysis.

Clinical Value

Tie

Both tools offer substantial clinical value in different phases of cardiac care. Tool A excels in long-term diagnosis and management of arrhythmias through continuous ECG analysis, while Tool B provides critical real-time guidance during complex ablation procedures. Their distinct applications make a direct comparison of overall clinical value challenging without specific outcome data.

Pricing & Value

Tie

Neither tool provides publicly available pricing information, making it impossible to conduct a head-to-head comparison on cost or overall value. Prospective customers would need to contact each company directly for pricing details.

Enterprise Readiness

Zio ECG Utilization Software (ZEUS) System

Tool A demonstrates superior enterprise readiness with explicit mentions of HIPAA compliance, implied BAA, and HL7-based EHR integration, alongside its cloud-based deployment. While Tool B integrates with existing EP systems, the lack of explicit statements regarding BAA and HIPAA compliance may require additional due diligence for enterprise adoption.

Innovation

Tie

Both tools represent significant innovation in their respective domains within cardiology. Tool A innovates in long-term diagnostic accuracy and remote patient monitoring through proprietary deep-learned algorithms. Tool B pushes the boundaries of real-time AI assistance during complex cardiac ablation procedures, offering real-time annotation of 3D anatomical and electrical maps.

Support & Docs

Zio ECG Utilization Software (ZEUS) System

Tool A provides a more robust and transparent support ecosystem, offering detailed Instructions for Use for various components, a Clinical Resource Center for professionals, Patient Support and FAQs, and clear customer care contact methods via phone and email. While Tool B offers a user manual, the extent of its publicly available support and documentation is less comprehensive.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Zio ECG Utilization Software (ZEUS) System VX1+
Name Zio ECG Utilization Software (ZEUS) System VX1+
Company iRhythm Technologies Volta Medical
Description AI-powered, cloud-based platform that analyzes continuous ECG data from wearable Zio monitors to aid physicians in the diagnosis and management of cardiac arrhythmias. AI-powered software that assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia.
Key Features AI algorithm for arrhythmia detection and classification; Continuous ECG data analysis (up to 14 days); Cloud-based data analytics (AWS EC2 platform); Proprietary deep-learned algorithms for enhanced diagnostic accuracy; ZioSuite web portal and mobile application for healthcare professionals; Comprehensive end-of-wear reports for physician review; Integration with Zio wearable biosensors (Zio monitor, Zio Watch); HL7-based EHR integration Real-time manual or automatic annotation of 3D anatomical and electrical maps of the human heart; Identification of spatio-temporal dispersed electrograms (DEs) during AF and AT procedures; AI-driven insights to assist electrophysiologists during ablation procedures; Compatibility with existing 510(k)-cleared catheters and specific data acquisition systems (e.g., Boston Scientific LabSystem Pro, GE HealthCare MacLab CardioLab EP Recording System, Abbott EnSite X 3D mapping system); Non-sterile reusable medical device; Simple user interface with color coding for electrogram dispersion (blue, orange, red); Booster mode for increased sensitivity during AT or slow AF; Provides cycle length estimation from electrograms
Specialties Cardiology, Family Medicine, Internal Medicine Cardiology

Videos

Demos, reviews, and walkthroughs featuring Zio ECG Utilization Software (ZEUS) System and VX1+.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Zio ECG Utilization Software (ZEUS) System aids in the diagnosis and management of cardiac arrhythmias by analyzing continuous ECG data from wearable Zio monitors. In contrast, VX1+ assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia.
ZEUS is a cloud-based platform (AWS EC2) that integrates with Zio wearable biosensors and offers HL7-based EHR integration. VX1+ is a software application designed to integrate with existing EP recording and 3D mapping systems, including specific Boston Scientific, GE HealthCare, and Abbott systems.
ZEUS analyzes continuous ECG data collected from wearable Zio monitors for up to 14 days. VX1+ identifies spatio-temporal dispersed electrograms (DEs) by analyzing data from existing EP recording and 3D mapping systems during ablation procedures.
Yes, ZEUS is designed for the diagnostic and management phase, providing insights from continuous ambulatory ECG monitoring. VX1+ is designed for the interventional phase, offering real-time assistance during cardiac ablation procedures.
ZEUS is applicable across Cardiology, Family Medicine, and Internal Medicine for arrhythmia diagnosis and management. VX1+ is specifically designed for electrophysiologists to assist during ablation procedures.
ZEUS utilizes proprietary deep-learned AI algorithms for arrhythmia detection and classification from continuous ECG data. VX1+ employs AI-driven insights for real-time identification of abnormal electrograms and spatio-temporal dispersed electrograms (DEs) during ablation procedures.
The Zio ECG Utilization Software (ZEUS) System is HIPAA compliant and implies a Business Associate Agreement (BAA) for handling Protected Health Information (PHI). For VX1+, HIPAA compliance and a BAA are not explicitly stated, but are expected for a medical device handling patient data in U.S. healthcare settings.

Backers

Who funded each tool's parent company.

Zio ECG Utilization Software (ZEUS) System

AI Tool Finder
AI-powered search. Results may not be comprehensive.